Summary of Use during Lactation

No information is available on the clinical use of caspofungin during breastfeeding. Caspofungin is indicated for use in infants over 3 months of age and it is poorly absorbed orally, so it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. However, no published experience exists with caspofungin during breastfeeding, therefore an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Fluconazole, Miconazole

Substance Name

Caspofungin

CAS Registry Number

162808-62-0

Drug Class

• Breast Feeding
• Lactation
• Antifungal Agents